PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for October 8, 2009 Add to my Yahoo! Subscribe to this News Feed Subscribe to this News Feed   
 

STEMCELL Technologies Inc. Introduces MethoCult® Express for Cord Blood Banks and Transplant Centers

STEMCELL Technologies Inc. (STEMCELL), a Vancouver-based life sciences company, announces the launch of MethoCult® Express, an innovative methylcellulose-based medium specifically formulated to allow enumeration of total colony-forming cells after only 7 days of culture.

Vancouver, British Columbia (PRWEB) October 8, 2009 -- STEMCELL Technologies Inc., a Vancouver-based life sciences company, announces the launch of MethoCult® Express, an innovative methylcellulose-based medium specifically formulated to allow enumeration of total colony-forming cells after only 7 days of culture. With this new medium, reliable information on hematopoietic progenitor cell numbers in cord blood can be obtained much earlier than with standard 14-day assays.

"Assessment of the stem and progenitor cell content of cord blood units is a critical, time-sensitive step for cord blood banks and transplant centers," says Bert Wognum, Senior Scientist at STEMCELL Technologies. "Performing CFC-assays in MethoCult® Express allows faster, easier and more standardized assessment of progenitor numbers than 14-day assays. Obtaining accurate CFC-assay results in as early as 7 days may be very helpful for cord blood banks and transplant centers because the need to assess the progenitor cell content and quality of cord blood units during processing and cryopreservation may assist in selecting the most suitable graft for transplantation." With MethoCult® Express, cultures can also be maintained for a total of 14 - 16 days to permit identification of different colony types on the basis of morphological criteria similar to standard CFC-assays.

For more information about MethoCult® Express, visit http://www.stemcell.com/news_info/methocult_express.aspx.

About STEMCELL Technologies
STEMCELL Technologies Inc is a leader in the development and marketing of specialty cell culture media, cell separation products and ancillary reagents for life science research. Driven by science and enabled by close interactions with global leaders in cell biology and medicine, STEMCELL delivers over 900 products to research scientists in more than 70 countries worldwide. To learn more about how STEMCELL helps to make research work, visit www.stemcell.com.

Contact
Kenneth To, PhD, MBA, Product Manager - Hematology
STEMCELL Technologies Inc.
604-675-7807

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1UaGlyLVNpbmctUHJvZi1GYWx1LUNvdXAtWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Printer Friendly Version
Adobe PDF Download PDF Version
Adobe PDF Download Reader Version
Blog This BlogThis
Share This ShareThis
CONTACT INFORMATION
Kenneth To, PhD, MBA, Product Manager
STEMCELL Technologies Inc
604-675-7807
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move